These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32451132)

  • 1. Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms.
    Lang X; Wang DM; Du XD; Jia QF; Chen DC; Xiu M; Wang L; Zhang X
    Schizophr Res; 2020 Aug; 222():291-296. PubMed ID: 32451132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia.
    Wang DM; Chen DC; Wang L; Zhang XY
    World J Biol Psychiatry; 2021 Jun; 22(5):325-334. PubMed ID: 32772768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.
    Xiu MH; Li Z; Chen DC; Chen S; Curbo ME; Wu HE; Tong YS; Tan SP; Zhang XY
    Schizophr Bull; 2020 Dec; 46(6):1498-1510. PubMed ID: 32390043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia.
    Wang DM; Du YX; Zhu RR; Tian Y; Chen JJ; Chen DC; Wang L; Zhang XY
    World J Biol Psychiatry; 2022 Sep; 23(7):517-524. PubMed ID: 34918615
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study.
    Chen XJ; Wang DM; Zhou HX; Zhu RR; Tian Y; Du YX; Chen JJ; Chen DC; Wang L; Zhang XY
    Gen Hosp Psychiatry; 2021; 71():108-113. PubMed ID: 34000518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms.
    Wu Z; Zhang XY; Wang H; Tang W; Xia Y; Zhang F; Liu J; Fu Y; Hu J; Chen Y; Liu L; Chen DC; Xiu MH; Kosten TR; He J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):34-8. PubMed ID: 21896300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in the Prevalence and Clinical Features of Comorbid Depressive Symptoms in Never-Treated Chinese Patients With First-Episode Schizophrenia.
    Wang DM; Zhang GY; Du XD; Jia QF; Qian ZK; Yin GZ; Chen DC; Xiu MH; Ning YP; Huang XB; Wu FC; Zhang XY
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31617969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia.
    Qu M; Wang J; Chen DC; Chen S; Xiu MH; Zhang XY
    Free Radic Biol Med; 2020 Nov; 160():887-893. PubMed ID: 32949664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients.
    Yang H; Zhang J; Yang M; Xu L; Chen W; Sun Y; Zhang X
    Asian J Psychiatr; 2023 Jan; 79():103400. PubMed ID: 36521406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Qi LY; Chen S; Cao LY; Chen DC; Xiu MH; Wang F; Wu GY; Lu L; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2009 May; 204(1):177-84. PubMed ID: 19139851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
    Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
    Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the link between cognitive deficit, self-esteem, alexithymia, and depressive symptom of schizophrenia.
    He C; Zhang X; Xia Q; Gao H; Yan J; Chen X; Yuan H; Zhang Y; Xie W; Zhu C
    Brain Behav; 2022 Jul; 12(7):e2648. PubMed ID: 35676241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
    Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
    Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.
    Huo L; Lu X; Wu F; Chang C; Ning Y; Zhang XY
    BMC Psychiatry; 2021 Dec; 21(1):606. PubMed ID: 34863137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers.
    Wang S; Yuan X; Pang L; Song P; Jia R; Song X
    Front Pharmacol; 2023; 14():1158254. PubMed ID: 37007024
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-related changes of superoxide dismutase activity in patients with schizophrenia.
    Đorđević VV; Lazarević D; Ćosić V; Knežević M; Đorđević VB
    Vojnosanit Pregl; 2017 Jan; 74(1):31-7. PubMed ID: 29350504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia.
    Yan F; Meng X; Cheng X; Pei W; Chen Y; Chen L; Zheng M; Shi L; Zhu C; Zhang X
    BMC Psychiatry; 2023 Jul; 23(1):538. PubMed ID: 37491201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.